lunes, 3 de febrero de 2025

First brain-delivered AAV therapy approved by FDA The gene therapy treats the rare genetic disease AADC deficiency by delivering a functional gene into the brain.

https://www.drugdiscoverynews.com/first-brain-delivered-aav-therapy-approved-by-fda-16214?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-9RShQAEmHNy_hnhLtOGQG_BtFlclBnTDoc-gXKHT7-5tUDUOVMzWocw2xOdtYeiKXzAMIDWY_l15LFKw_NnEsje6CT_w&_hsmi=345185901&utm_content=345185901&utm_source=hs_email

No hay comentarios:

Publicar un comentario